SIB-Norwegian Version, Validation and Reliability Study

Sponsor
Sykehuset Innlandet HF (Other)
Overall Status
Completed
CT.gov ID
NCT00449384
Collaborator
(none)
59
1
2.9
20.2

Study Details

Study Description

Brief Summary

The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Diagnostic Screening

Detailed Description

The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.

Study Design

Study Type:
Observational
Actual Enrollment :
59 participants
Observational Model:
Defined Population
Time Perspective:
Other
Official Title:
Severe Impairment Study - Norwegian Version. A Validation and Reliability Study.
Study Start Date :
Feb 1, 2007
Actual Study Completion Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Dementia, mild to severe.

    • Nursing Home resident

    Exclusion Criteria:
    • No ability to write or read.

    • Physical handicapped, unable to use hands.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sykehuset Innlandet HF - Sanderud Ottestad Oppland Norway 2312

    Sponsors and Collaborators

    • Sykehuset Innlandet HF

    Investigators

    • Study Chair: Knut Engedal, PhD, The Norwegian Centre for Dementia Research (NCDR), Norway

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00449384
    Other Study ID Numbers:
    • F06002
    First Posted:
    Mar 20, 2007
    Last Update Posted:
    Jul 3, 2007
    Last Verified:
    Jul 1, 2007
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 3, 2007